Bartkowiak D - Search Results

1

Absence of inflammatory response from upper airway epithelial cells after X irradiation.

Reiter R, Deutschle T, Wiegel T, Riechelmann H, Bartkowiak D. Reiter R, et al. Among authors: bartkowiak d. Radiat Res. 2009 Mar;171(3):274-82. doi: 10.1667/RR1535.1. Radiat Res. 2009. PMID: 19267554

2

Radiation- and chemoinduced multidrug resistance in colon carcinoma cells.

Bartkowiak D, Stempfhuber M, Wiegel T, Bottke D. Bartkowiak D, et al. Strahlenther Onkol. 2009 Dec;185(12):815-20. doi: 10.1007/s00066-009-1993-9. Strahlenther Onkol. 2009. PMID: 20013091

3

Second malignancies in high‑dose areas of previous tumor radiotherapy.

Welte B, Suhr P, Bottke D, Bartkowiak D, Dörr W, Trott KR, Wiegel T. Welte B, et al. Among authors: bartkowiak d. Strahlenther Onkol. 2010 Mar;186(3):174-9. doi: 10.1007/s00066-010-2050-4. Epub 2010 Feb 22. Strahlenther Onkol. 2010. PMID: 20339826

4

Radiotherapy in the management of prostate cancer after radical prostatectomy.

Bartkowiak D, Bottke D, Wiegel T. Bartkowiak D, et al. Future Oncol. 2013 May;9(5):669-79. doi: 10.2217/fon.13.3. Future Oncol. 2013. PMID: 23647296 Review.

5

Radiotherapy after radical prostatectomy: immediate or early delayed?

Bottke D, Bartkowiak D, Schrader M, Wiegel T. Bottke D, et al. Among authors: bartkowiak d. Strahlenther Onkol. 2012 Dec;188(12):1096-101. doi: 10.1007/s00066-012-0234-9. Epub 2012 Nov 7. Strahlenther Onkol. 2012. PMID: 23128897

6

Second cancer after radiotherapy, 1981-2007.

Bartkowiak D, Humble N, Suhr P, Hagg J, Mair K, Polivka B, Schneider U, Bottke D, Wiegel T. Bartkowiak D, et al. Radiother Oncol. 2012 Oct;105(1):122-6. doi: 10.1016/j.radonc.2011.09.013. Epub 2011 Oct 10. Radiother Oncol. 2012. PMID: 21993405

7

Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancer.

Bartkowiak D, Bottke D, Wiegel T. Bartkowiak D, et al. Curr Opin Urol. 2013 Jul;23(4):360-5. doi: 10.1097/MOU.0b013e328361d3ed. Curr Opin Urol. 2013. PMID: 23619579 Review.

8

PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancer.

Wiegel T, Stöckle M, Bartkowiak D. Wiegel T, et al. Among authors: bartkowiak d. Eur Urol. 2015 Jan;67(1):1-2. doi: 10.1016/j.eururo.2014.09.016. Epub 2014 Sep 27. Eur Urol. 2015. PMID: 25269383 Clinical Trial. No abstract available.

9

Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer.

Bottke D, de Reijke TM, Bartkowiak D, Wiegel T. Bottke D, et al. Among authors: bartkowiak d. Eur J Cancer. 2009 Sep;45 Suppl 1:148-57. doi: 10.1016/S0959-8049(09)70027-9. Eur J Cancer. 2009. PMID: 19775613 No abstract available.

10

[Adjuvant vs. salvage radiotherapy after radical prostatectomy].

Bartkowiak D, Schrader AJ, Wiegel T. Bartkowiak D, et al. Aktuelle Urol. 2015 Jan;46(1):52-8. doi: 10.1055/s-0034-1395656. Epub 2015 Feb 6. Aktuelle Urol. 2015. PMID: 25658231 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters